BioNTech Pharmaceutical company that made a name for itself with the first coronavirus vaccine developed together with Pfizer, this time too COVID-19 pill announced its development. The company published the first trial results today. The second-of-its-kind antiviral pill for at-risk patients with mild to moderate infections. hospitalization and death rates approximately 90 percent rate decreased. Here are all the details of the study…
Another side effect of COVID-19 has emerged!
Another side effect of COVID-19 has been identified… The reason for the dizziness seen in COVID-19 patients may be related to the inner ear!
Pfizer says “90 percent effective” for COVID-19 pill
The US-based pharmaceutical company announced that the pill it developed is a priority, especially for the elderly and those with health problems. ‘PaxlovidAnnouncement of the drug named ‘, pharmaceutical company MerckIt came right after the coronavirus drug announced by . A drug developed by Merck has halved the rate of death or hospitalization in patients at high risk of serious illness.
Pfizer has announced the details of its COVID-19 pill trials. Patients with mild to moderate illness 775 unvaccinated made on humans. patients, obesity or old age had at least one risk factor for serious disease development, such as Treatment after symptoms appear three to five days It started in and lasted for five days.
The researchers found that only percent of people who were given the pill within three days of the onset of symptoms. 0.8 of them were hospitalized saw it removed. None had died 28 days after treatment. In addition, seven percent of patients in the placebo group were hospitalized. Seven people in the placebo group died.
The rate was similar in patients treated with the Pfizer COVID-19 pill within five days of symptoms onset. Only those in Pfizer’s treatment group 1% hospitalized. In contrast, 10 people in the placebo group died.
Pfizer did not disclose side effects
Pharmaceutical company Pfizer said: “If approved by regulatory authorities, our candidate for oral antiviral drug can save patients’ lives, reduce the severity of COVID-19 infections and Nine out of 10 hospitalizations We show that it has the potential to prevent it.” said.
Pfizer, COVID-19 pill for any side effect has not disclosed yet. However, the side effects of treatment and placebo patients were approximately in 20 percent seen. However, because the drug was not given alone in the Pfizer trial in question, the company said these side effects could be caused by the other drug.
If the drug is approved, daily treatment consisting of three pills taken twice, may be useful in countries with low vaccination rates. In addition, Pfizer discontinued the work on the advice of an independent expert group, due to the positive results of the trials.
The company will apply for approval to international drug regulators, including the U.S. Food and Drug Administration. Meanwhile, the UK is already 250 thousand ordered the treatment dose.